Table 5

Multivariable analysis of impact of amino acid substitution on HLA class I molecules for severe aGVHD

Posisiton and kind of amino acid substitution, donor-recipientHSNEventHR (95% CI)P
HLA-A locus      
    Tyr9A-Phe9A 4.1 163 64 1.66 (1.19-2.32) .003 
    Asn116A-Asp116A 32 15 2.25 (1.26-4.01) .005* 
HLA-C locus      
    Tyr9C-Ser9C 0.5 146 59 1.66 (1.23-2.25) .001 
    Asn77C-Ser77C 2.7 205 90 1.87 (1.46-2.39) < .001 
    Lys80C-Asn80C 0.4 205 90 1.87 (1.46-2.39) < .001 
    Tyr99C-Phe99C 4.1 146 59 1.64 (1.21-2.22) .001 
    Leu116C-Ser116C 4.6 53 30 3.40 (2.20-5.25) < .001 
    Arg156C-Leu156C 8.3 251 88 1.48 (1.15-1.90) .002 
Posisiton and kind of amino acid substitution, donor-recipientHSNEventHR (95% CI)P
HLA-A locus      
    Tyr9A-Phe9A 4.1 163 64 1.66 (1.19-2.32) .003 
    Asn116A-Asp116A 32 15 2.25 (1.26-4.01) .005* 
HLA-C locus      
    Tyr9C-Ser9C 0.5 146 59 1.66 (1.23-2.25) .001 
    Asn77C-Ser77C 2.7 205 90 1.87 (1.46-2.39) < .001 
    Lys80C-Asn80C 0.4 205 90 1.87 (1.46-2.39) < .001 
    Tyr99C-Phe99C 4.1 146 59 1.64 (1.21-2.22) .001 
    Leu116C-Ser116C 4.6 53 30 3.40 (2.20-5.25) < .001 
    Arg156C-Leu156C 8.3 251 88 1.48 (1.15-1.90) .002 

HLA-B. -DRB1, -DQB1 -DPB1 locus had no significant substitutions. The impact of positions and types of amino acid substitution in HLA molecules was evaluated in pairs with HLA one-locus mismatch in HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 separately. For example, Tyr9A-Phe9A indicated amino acid substitutions of position 9 in HLA-A molecule at which donor had tyrosine and patient phenylalanine. The impacts of positions and kinds of amino acid substitutions in each HLA molecule were evaluated in pairs with HLA one locus mismatch in each HLA locus separately. Pairs which substituted specific amino acid at each position were compared with amino acid matched pairs at that position.

HS indicates hydropathy scale; HR, hazard ratio; CI, confidence interval; Tyr, tyrosine; Phe, phenylalanine; Asn, asparagine; Asp, asparatic acid; Ser, serine; Lys, lysine; Leu, leucine; and Arg, arginine.

*

Result of base analysis was significant but result of validating analysis using bootstrap resampling was not. Results of analysis were thus judged not to be statistically significant.

Measured in number of occurrences of severe acute GVHD.

or Create an Account

Close Modal
Close Modal